The Kable

The Kable

Share this post

The Kable
The Kable
💉 Lilly widens RNA editing pact; Merck targets cancer; Merck too targets cancer
Copy link
Facebook
Email
Notes
More
Friday Kable

💉 Lilly widens RNA editing pact; Merck targets cancer; Merck too targets cancer

#244 | The Kable will be back in your inbox in 2023

Ria's avatar
Vinod's avatar
Ria
and
Vinod
Dec 23, 2022
∙ Paid
2

Share this post

The Kable
The Kable
💉 Lilly widens RNA editing pact; Merck targets cancer; Merck too targets cancer
Copy link
Facebook
Email
Notes
More
Share

Hello, and welcome back to The Kable for what is our last issue of 2022. Thank you for reading The Kable all year long. We will be back on January 2nd, 2023 to take you through what could be a potentially world-changing year. Vaccines for malaria, herpes, RSV, Chikungunya are all on the anvil. Maybe Covid will actually be over, for real. Africa will be …

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More